• DOI:10.1176/APPI.AJP.160.4.790
Corpus ID: 20755149

Suicide rates in clinical trials of SSRIs, other antidepressants, and placebo: analysis of FDA reports.

@article{Khan2003SuicideRI,
  title={Suicide rates in clinical trials of SSRIs, other antidepressants, and placebo: analysis of FDA reports.},
  author={A. Khan and S. Khan and R. Kolts and W. Brown},
  journal={The American journal of psychiatry},
  year={2003},
  volume={160 4},
  pages={
          790-2
        }
}

A. Khan, S. Khan, +1 author W. Brown

Published 2003

Psychology, Medicine

The American journal of psychiatry

OBJECTIVE Previous reports suggesting that selective serotonin reuptake inhibitor (SSRI) use is associated with increased suicidal risk have not assessed completed suicides. The authors analyzed reports from randomized controlled trials to compare suicide rates among depressed patients assigned to an SSRI, other antidepressants, or placebo. METHOD Food and Drug Administration (FDA) summary reports of the controlled clinical trials for nine modern FDA-approved antidepressants provided data for… CONTINUE READING

View PDF

Save to Library

Create Alert

Cite

Launch Research Feed